Skip to main content
SpringerLink
Log in

Positronen-Emissions-Tomographie bei Demenz vom Alzheimer-Typ

  • Conference paper
Frühdiagnostik und Frühbehandlung psychischer Störungen

Part of the book series: Bayer-ZNS-Symposium ((BAYERZNS,volume 13))

  • 91 Accesses

Zusammenfassung

Wegen der diagnostischen Unsicherheit der aktuellen Klassifikations- kriterien wird nach biologischen Markern für eine sichere Differenzierung der Alzheimer-Demenz (AD) von den vaskulären Demenzen (VD) und normalen altersabhängigen Veränderungen gesucht. Bei der AD führen progressiver Zellverlust, verminderte Zelldichte und Synapsenaktivität zu einer Verminderung von Glukosestoffwechsel und Durchblutung nach einem charakteristischen Muster vor allem im temporalen, parietalen und okzipitalen Assoziationskortex. Zur Früherkennung solcher Funktionsstörungen eignen sich daher funktionelle bild- gebende Verfahren wie die Positronen-Emissions-Tomographie (PET). Diese scheint nach heutigem Wissensstand das beste Verfahren zur Quantifizierung des regionalen zerebralen Glukosestoffwechsels und damit zur Darstellung der die AD begleitenden metabolischen Veränderungen zu sein. Aus der Untersuchung des Glukosestoffwechsels mittels PET ergeben sich wichtige Hinweise auf die Ätiologie von Gedächtnis- und kognitiven Einbußen, wobei die direkte Beziehung zwischen Schweregrad der Demenz und regionaler Verminderung des Glukosestoffwechsels auch als quantifizierbarer Marker für therapeutische Studien herangezogen werden kann.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Alavi A, Newberg AB, Souder E, Berlin JA (1993) Quantitative analysis of PET and MRI data in normal aging and Alzheimer’s disease — atrophy weighted total brain metabolism and absolute whole-brain metabolism as reliable discriminators. J Nucl Med 34:1681–1687

    PubMed  CAS  Google Scholar 

  • Amaducci L (1988) Phosphatidylserine in the treatment of Alzheimer’s disease: Results of a multicenter study. Psychopharmacol Bull 24: 130–134

    PubMed  CAS  Google Scholar 

  • Andine P, Rudolphi KA, Fredholm BB, Hagberg H (1990) Effect of propentofylline (HWA 285) on extracellular purines and excitatory amino acids in CA1 of rat hippocampus during transient ischaemia. Br J Pharmacol 100: 814–818

    PubMed  CAS  Google Scholar 

  • Baxter LR Jr, Schwartz JM, Phelps ME, Mazziotta JC, Guze BH, Selin CE, Gerner RH, Sumida RM (1989) Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 46: 243–250

    Article  PubMed  CAS  Google Scholar 

  • Benson DF (1993) Progressive frontal dysfunction. Dementia 4:149–153

    PubMed  CAS  Google Scholar 

  • Benson DF, Kuhl DE, Hawkins RA, Phelps ME, Cummings JL, Tsai SY (1983) The fluorodeoxyglucose 18F scan in Alzheimer’s disease and multi-infarct dementia. Arch Neurol 40: 711–714

    Article  PubMed  CAS  Google Scholar 

  • Blin J, Baron JC, Dubois B, Pillon B, Cambon H, Cambier J, Agid Y (1990) Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolism pattern and clinicometabolic correlations. Arch Neurol 47: 747–752

    Article  PubMed  CAS  Google Scholar 

  • Brun A (1993) Frontal-lobe degeneration of non-Alzheimer type revisited. Dementia 4:126–131

    PubMed  CAS  Google Scholar 

  • Buchsbaum MS, Kesslak JP, Lynch G, Chui H, Wu J, Sicotte N, Hazlett E, Teng E, Cotman CW (1991) Temporal and hippocampal metabolic rate during an olfactory memory task assessed by positron emission tomography in patients with dementia of the Alzheimer type and controls — preliminary studies. Arch Gen Psychiatry 48: 840–847

    Article  PubMed  CAS  Google Scholar 

  • Buchsbaum MS, Haier RJ, Potkin SG, Nuechterlein K, Bracha HS, Katz M, Lohr J, Wu J, Lottenberg S, Jerabek PA, Trenary M, Tafalla R, Reynolds C, Bunney WE Jr (1992) Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics. Arch Gen Psychiatry 49:935–942

    Article  PubMed  CAS  Google Scholar 

  • Chase TN, Burrows GH, Mohr E (1987) Cortical glucose utilization patterns in primary degenerative dementias of the anterior and posterior type. Arch Gerontol Geriatr 6: 289–297

    Article  PubMed  CAS  Google Scholar 

  • Chawluk JB, Mesulam MM, Hurtig H, Kushner M, Weintraub S, Saykin A, Rubin N, Alavi A, Reivich M (1986) Slowly progressive aphasia without generalized dementia: studies with positron emission tomography. Ann Neurol 19: 68–74

    Article  PubMed  CAS  Google Scholar 

  • Chawluk JB, Alavi A, Dann R, Hurtig HI, Bais S, Kushner MJ, Zimmerman RA, Reivich M (1987) Positron emission tomography in aging and dementia: effect of cerebral atrophy. J Nucl Med 28: 431–437

    PubMed  CAS  Google Scholar 

  • Cooper AJ, Magnus RV (1980) A placebo-controlled study of pyritinol (Enzephabol) in dementia. Pharmatherapeutica 2: 317–322

    PubMed  CAS  Google Scholar 

  • Crook T, Petrie W, Wells C, Massari DC (1992) Effects of phosphatidylserine in Alzheimer’s disease. Psychopharmacol Bull 28: 61–66

    PubMed  CAS  Google Scholar 

  • Cutler NR, Haxby JV, Duara R, Grady CL, Moore AM, Parisi JE, White J, Heston L, Margolin RM, Rapoport SI (1985) Brain metabolism as measured with positron emission tomography: serial assessment in a patient with familial Alzheimer’s disease. Neurology 35:1556–1561

    PubMed  CAS  Google Scholar 

  • DeCarli C, Atack JR, Ball MJ, Kaye JA, Grady CL, Fewster P, Pettigrew KD, Rapoport SI, Schapiro MB (1991) The relation between neurofibrillary tangle density and regional cerebral metabolic rates for glucose in Alzheimer’s disease. Ann Neurol 30: 247–248

    Google Scholar 

  • DeKosky ST, Scheff WS (1990) Synapse loss in frontal cortex biopsies in Alzheimer’s disease: Correlation with cognitive severity. Ann Neurol 27: 457–464

    Article  PubMed  CAS  Google Scholar 

  • DeLeon MJ, Ferris SH, George AE, Reisberg B, Christman DR, Kricheff II, Wolf AP (1983) Computed tomography and positron emission transaxial tomography evaluations of normal aging and Alzheimer’s disease. J Cereb Blood Flow Metab 3: 391–394

    Article  CAS  Google Scholar 

  • Duara R, Grady C, Haxby J, Sundaram M, Cutler NR, Heston L, Moore A, Schlageter N, Larson S, Rapoport SI (1986) Positron emission tomography in Alzheimer’s disease. Neurology 36:879–887

    PubMed  CAS  Google Scholar 

  • Duara R, Barker WW, Chang J, Yoshii F, Loewenstein DA, Pascal S (1992) Viability of neocortical function shown in behavioral activation state. PET studies in Alzheimer’s disease. J Cereb Blood Flow Metab 12: 927–934

    Article  PubMed  CAS  Google Scholar 

  • Erkinjuntti T, Hachinski VC (1993) Rethinking vascular dementia. Cerebrovasc Dis 3:3–23

    Article  Google Scholar 

  • Foster NL, Chase TN, Fedio P, Patronas NJ, Brooks RA, DiChiro G (1983) Alzheimer’s disease: Focal cortical changes shown by positron emission tomography. Neurology 33:961–965

    PubMed  CAS  Google Scholar 

  • Foster NL, Gilman S, Berent S, Morin EM, Brown MB, Koeppe RA (1988) Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography. Ann Neurol 24: 399–406

    Article  PubMed  CAS  Google Scholar 

  • Friedland RP, Budinger TF, Ganz E, Yano Y, Mathis CA, Koss B, Ober BA, Huesman RH, Derenzo SE (1983) Regional cerebral metabolic alterations in dementia of the Alzheimer type: Positron emission tomography with (18F)fluorodeoxyglucose. J Comput Assist Tomogr 7:590–598

    Article  PubMed  CAS  Google Scholar 

  • Friedland RP, Koss E, Lerner A, Hedera P, Ellis W, Dronkers N, Ober BA, Jagust WJ (1993) Functional imaging, the frontal lobes, and dementia. Dementia 4:192–203

    PubMed  CAS  Google Scholar 

  • Fukuyama H, Harada K, Yamauchi H, Miyoshi T, Yamaguchi S, Kimura J, Kameyama M, Senda M, Yonekura Y, Konishi J (1991) Coronal reconstruction images of glucose metabolism in Alzheimer’s disease. J Neurol Sci 106:128–134

    Article  PubMed  CAS  Google Scholar 

  • Gemmel HG, Evans NTS, Besson JAO, Roeda D, Davidson J, Dodd MG, Sharp PF, Smith FW, Crawford JR, Newton RH, Kulkarni V, Mallard JR (1990) Regional cerebral blood flow imaging: a quantitative comparison of technetium-99m-HMPAO SPECT with (C02)0–15 PET. J Nucl Med 31: 1595–1600

    Google Scholar 

  • Gilman S, Adams K, Koeppe RA, Berent S, Kluin KJ, Modell JG, Kroll P, Brunberg JA (1990) Cerebellar and frontal hypometabolism in alcoholic cerebellar degeneration studies with positron emission tomography. Ann Neurol 28: 775–785

    Article  PubMed  CAS  Google Scholar 

  • Grady CL, Haxby JV, Schlageter NL, Berg G, Rapoport SI (1986) Stability of metabolic and neuropsychological asymmetries in dementia of the Alzheimer type. Neurology 36:1390–1392

    PubMed  CAS  Google Scholar 

  • Grady CL, Haxby JV, Horwitz B, Sundaram M, Berg G, Schapiro M, Friedland RP, Rapoport SI (1988) Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer type. J Clin Exp Neuropsychol 10: 576–596

    Article  PubMed  CAS  Google Scholar 

  • Guze BH, Baxter LR, Schwartz JM, Szuba MP, Mazziotta JC, Phelps ME (1991) Changes in glucose metabolism in dementia of the Alzheimer type compared with depression — a preliminary report. Psychiatry Res 40: 195–202

    Article  PubMed  CAS  Google Scholar 

  • Guze BH, Hoffman JM, Mazziotta JC, Baxter LR Jr, Phelps ME (1992) Positron emission tomography and familial Alzheimer’s disease: a pilot study. J Am Geriatr Soc 40:120–123

    PubMed  CAS  Google Scholar 

  • Haxby JV, Duara R, Grady CL, Cutler NR, Rapoport SI (1985) Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer’s disease. J Cereb Blood Flow Metab 5:193–200

    Article  PubMed  CAS  Google Scholar 

  • Haxby JV, Grady CL, Koss E, Horwitz B, Schapiro M, Friedland RP, Rapoport SI (1988) Heterogeneous anterior-posterior metabolic patterns in dementia of the Alzheimer type. Neurology 38: 1853–1863

    PubMed  CAS  Google Scholar 

  • Haxby JV, Grady CL, Koss E, Horwitz B, Heston L, Schapiro M, Friedland RP, Rapoport SI (1990) Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. Arch Neurol 47: 753–760

    Article  PubMed  CAS  Google Scholar 

  • Heiss W-D, Beil C, Herholz K, Pawlik G, Wagner R, Wienhard K (1985) Atlas der Positronen-Emissions-Tomographie des Gehirns. Springer, Berlin-Heidelberg-New York-Tokyo

    Google Scholar 

  • Heiss W-D, Hebold I, Klinkhammer P, Ziffling P, Szelies B, Pawlik G, Herholz K (1988) Effect of piracetam on cerebral glucose metabolism in Alzheimer’s disease as measured by PET. J Cereb Blood Flow Metab 8:613–617

    Article  PubMed  CAS  Google Scholar 

  • Heiss W-D, Herholz K, Pawlik G, Hebold I, Klinkhammer P, Szelies B (1989) PET findings in dementia disorders. Contributions to differential diagnosis and objectivizing of therapeutic effects. Keio J Med 38:111–135

    Article  PubMed  CAS  Google Scholar 

  • Heiss W-D, Pawlik G, Holthoff V, Kessler J, Szelies B (1992) PET correlates of normal and impaired memory functions. Cerebrovasc Brain Metab Rev 4:1–27

    PubMed  CAS  Google Scholar 

  • Heiss W-D, Kessler J, Mielke R, Szelies B, Herholz K (1994) Long-term effects of phosphati-dylserine, pyritinol, and cognitive training in Alzheimer’s disease. Dementia 5: 88–98

    PubMed  CAS  Google Scholar 

  • Herholz K (1995) FDG PET and differential diagnosis of dementia. Alzheimer Dis Assoc Disord 9: 6–16

    Article  PubMed  CAS  Google Scholar 

  • Herholz K, Adams R, Kessler J, Szelies B, Grond M, Heiss W-D (1990) Criteria for the diagnosis of Alzheimer’s disease with positron emission tomography. Dementia 1:156–164

    Google Scholar 

  • Herholz K, Perani D, Salmon E, Franck F, Fazio F, Heiss W-D, Comar D (1993) Comparability of FDG PET studies in probable Alzheimer’s disease. J Nucl Med 34:1460–1466

    PubMed  CAS  Google Scholar 

  • Herholz K, Halber M, Nordberg A, Salmon E, Perani D, Heiss W-D. (for the EC Study Group) (1998) A multi-center study of the diagnostic value of FDG PET in possible Alzheimer’s disease. In press

    Google Scholar 

  • Jagust WJ, Friedland RP, Budinger TF, Koss E, Ober B (1988) Longitudinal studies of regional cerebral metabolism in Alzheimer’s disease. Neurology 38: 909–912

    PubMed  CAS  Google Scholar 

  • Kamo H, McGeer PL, Harrop R, McGeer EG, Calne DB, Martin WRW, Pate BD (1987) Positron emission tomography and histopathology in Pick’s disease. Neurology 37: 439–445

    PubMed  CAS  Google Scholar 

  • Karbe H, Grond M, Huber M, Herholz K, Kessler J, Heiss W-D (1992) Subcortical damage and cortical dysfunction in progressive supranuclear palsy demonstrated by positron emission tomography. J Neurol 239: 98–102

    Article  PubMed  CAS  Google Scholar 

  • Kempler D, Metter EJ, Riege WH, Jackson CA, Benson DF, Hanson WR (1990) Slowly progressive aphasia — 3 cases with language, memory, CT and PET data. J Neurol Neurosurg Psychiatry 53:987–993

    Article  PubMed  CAS  Google Scholar 

  • Kessler J, Herholz K, Grond M, Heiss W-D (1991) Impaired metabolic activation in Alzheimer’s disease: A PET study during continuous visual recognition. Neuropsychologia 29:229–243

    Article  PubMed  CAS  Google Scholar 

  • Klinkhammer P, Szelies B, Heiss W-D (1990) Effect of phosphatidylserine on cerebral glucose metabolism in Alzheimer’s disease. Dementia 1:197–201

    Google Scholar 

  • Kuhl DE, Metter EJ, Benson DF, Ashford JW, Riege WH, Fujikawa DG, Markham CH, Mazziotta JC, Maltese A, Dorsey DA (1985) Similarities of cerebral glucose metabolism in Alzheimer’s and Parkinsonian dementia. J Cereb Blood Flow Metab 5 (Suppl. 1): 169–170

    Google Scholar 

  • Kumar A, Newberg A, Alavi A, Berlin J, Smith R, Reivich M (1993) Regional cerebral glucose metabolism in late-life depression and Alzheimer’s disease — a preliminary positron emission tomography study. Proc Natl Acad Sci USA 90: 7019–7023

    Article  PubMed  CAS  Google Scholar 

  • Kuwert T, Hömberg V, Steinmetz H, Unverhau S, Langen K-J, Herzog H, Feinendegen LE (1993) Posthypoxic amnesia: regional cerebral glucose consumption measured by positron emission tomography. J Neurol Sci 118:10–16

    Article  PubMed  CAS  Google Scholar 

  • Marcusson, J. European Propentofylline Study Group (1995) HWA 285 for the treatment of dementia — results of a 12 months clinical trial. J Cereb Blood Flow Metab 15 (Suppl. 1): 107

    Google Scholar 

  • Marsh JT, Schubarth G, Brown WS, Riege W, Strandburg R, Dorsey D, Maltese A, Kuhl D (1990) PET and P300 relationships in early Alzheimer’s disease. Neurobiol Aging 11: 471–476

    Article  PubMed  CAS  Google Scholar 

  • McGeer PL, Kamo H, Harrop R, Li DKB, Tuokko H, McGeer EG, Adam MJ, Ammann W, Beattie BL, Calne DB, Martin WRW, Pate DB, Rogers SG, Ruth TJ, Sayre CI, Stoessl AJ (1986) Positron emission tomography in patients with clinically diagnosed Alzheimer’s disease. Can Med Assoc J 134: 597–607

    CAS  Google Scholar 

  • Messa C, Perani D, Lucignani G, Zenorini A, Zito F, Rizzo G, Grassi F, del Sole A, Franceschi M, Gilardi MC, Fazio F (1994) High-resolution technetium-99m-HMPAO SPECT in patients with probable Alzheimer’s disease: comparison with fluorine-18-FDG PET. J Nucl Med 35:210–216

    PubMed  CAS  Google Scholar 

  • Micheli E de, Pietrini P, Grady CL, Haxby JV, Salerno J, Gonzales-Aviles A, Schapiro MB (1992) Alzheimer’s disease with prominent visual impairment: a longitudinal PET study of cerebral glucose metabolism. Neurobiol Aging 13 (Suppl. 1): 14

    Google Scholar 

  • Mielke R, Herholz K, Grond M, Kessler J, Heiss W-D (1992a) Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type. Neurobiol Aging 13: 93–98

    Article  PubMed  CAS  Google Scholar 

  • Mielke R, Herholz K, Grond M, Kessler J, Heiss W-D (1992b) Severity of vascular dementia is related to volume of metabolically impaired tissue. Arch Neurol 49: 909–913

    Article  PubMed  CAS  Google Scholar 

  • Mielke R, Herholz K, Grond M, Kessler J, Heiss W-D (1994a) Clinical deterioration in probable Alzheimer’s disease correlates with progressive metabolic impairment of association areas. Dementia 5: 36–41

    PubMed  CAS  Google Scholar 

  • Mielke R, Pietrzyk U, Jacobs A, Fink GR, Ischimiya A, Kessler J, Herholz K, Heiss W-D (1994b) HMPAO SPET and FDG PET in Alzheimer’s disease and vascular dementia: comparison of perfusion and metabolic pattern. Eur J Nucl Med 21:1052–1060

    Article  PubMed  CAS  Google Scholar 

  • Mielke R, Kessler J, Fink G, Herholz K, Heiss W-D (1995) Dysfunction of visual cortex contributes to disturbed processing of visual information in Alzheimer’s disease. Int J Neurosci 82:1–9

    Article  PubMed  CAS  Google Scholar 

  • Mielke R, Schröder R, Fink GR, Kessler J, Herholz K, Heiss W-D (1996) Regional cerebral glucose metabolism and postmortem pathology in Alzheimer’s disease. Acta Neuropathol 91:174–179

    Article  PubMed  CAS  Google Scholar 

  • Mielke R, Ghaemi M, Kessler J, Kittner B, Szelies B, Herholz K, Heiss W-D (1998) Activation PET demonstrates neurotrophic properties of propentofylline in Alzheimer’s disease. J Neurol Sci 154: 76–82

    Article  PubMed  CAS  Google Scholar 

  • Miller JD, deLeon MJ, Ferris SH, Kluger A, George AE, Reisberg B, Sachs HJ, Wolf AP (1987) Abnormal temporal lobe response in Alzheimer’s disease during cognitive processing as measured by 11C-2-deoxy-D-glucose and PET. J Cereb Blood Flow Metab 7:248–251

    Article  PubMed  CAS  Google Scholar 

  • Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE (1995) A diagnostic approach in Alzheimer’s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 36:1238–1248

    PubMed  CAS  Google Scholar 

  • Nordberg A, Lilja A, Lundqvist H, Hartvig P, Amberla K, Viitanen M, Warpman U, Johansson M et al. (1992) Tacrine restores cholinergic nicotinic receptors and glucose metabolism in Alzheimer patients as visualized by positron emission tomography. Neurobiol Aging 13: 747–758

    Article  PubMed  CAS  Google Scholar 

  • Perani D, Bressi S, Cappa SF, Vallar G, Alberoni M, Grassi F, Caltagirone C, Cipolotti L, Franceschi M, Lenzi GL, Fazio F (1993) Evidence of multiple memory systems in the human brain. A (18F)FDG PET metabolic study. Brain 116: 903–919

    Article  PubMed  Google Scholar 

  • Phelps ME, Mazziotta JC, Huang SC (1982) Study of cerebral function with positron computed tomography. J Cereb Blood Flow Metab 2:113–162

    Article  PubMed  CAS  Google Scholar 

  • Polich J (1991) P300 in the evaluation of aging and dementia. Electroenceph Clin Neurophysiol 42 (Suppl.): 304–323

    CAS  Google Scholar 

  • Polinsky RJ, Noble H, Di Chiro G, Nee LE, Feldman RG, Brown RT (1987) Dominantly inherited Alzheimer’s disease: cerebral glucose metabolism. J Neurol Neurosurg Psychiatry 50: 752–757

    Article  PubMed  CAS  Google Scholar 

  • Rapoport SI (1991) Positron emission tomography in Alzheimer’s disease in relation to disease pathogenesis: A critical review. Cerebrovasc Brain Metab Rev 3: 297–335

    PubMed  CAS  Google Scholar 

  • Reisberg B, Ferris SH, DeLeon MJ, Crook T (1982) The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry 139:1136–1139

    PubMed  CAS  Google Scholar 

  • Salmon E, Franck G (1989) Positron emission tomographic study in Alzheimer’s disease and Pick’s disease. Arch Gerontol Geriatr (Suppl. 1): 241–247

    Google Scholar 

  • Salmon E, Sadzot B, Maquet P, Dive D, Franck G (1989) Slowly progessive aphasia syndrome -a positron emission tomographic study. Acta Neurol (Belg) 89:242–245

    CAS  Google Scholar 

  • Schapiro MB, Ball MJ, Grady CL, Haxby JV, Kaye JA, Rapoport SI (1988) Dementia in Down’s syndrome: cerebral glucose utilization, neuropsychological assessment, and neuropathology. Neurology 38: 938–942

    PubMed  CAS  Google Scholar 

  • Shinoda I, Furukawa Y, Furukawa S (1990) Stimulation of nerve growth factor synthesis/secretion by propentofylline in cultured mouse astroglial cells. Biochem Pharmacol 39:1813–1816

    Article  PubMed  CAS  Google Scholar 

  • Slansky I, Herholz K, Pietrzyk U, Kessler J, Grond M, Mielke R, Heiss W-D (1995) Cognitive impairment in Alzheimer’s disease correlates with ventricular width and atrophy-corrected cortical glucose metabolism. Neuroradiology 37: 270–277

    Article  PubMed  CAS  Google Scholar 

  • Swets JA (1988) Measuring the accuracy of diagnostic systems. Science 240:1285

    Article  PubMed  CAS  Google Scholar 

  • Szelies B, Karenberg A (1986) Störungen des Glukosestoffwechsels bei Pick’scher Erkrankung. Fortschr Neurol Psychiatr 54:393–397

    Article  PubMed  CAS  Google Scholar 

  • Szelies B, Herholz K, Pawlik G, Beil C, Wienhard K, Heiss W-D (1986) Zerebraler Glukosestoffwechsel bei präseniler Demenz vom Alzheimer-Typ — Verlaufskontrolle unter Therapie mit muskarinergem Cholinagonisten. Fortschr Neurol Psychiatr 54: 364–373

    Article  PubMed  CAS  Google Scholar 

  • Szelies B, Grond M, Herholz K, Kessler J, Wullen T, Heiss W-D (1992) Quantitative EEG mapping and PET in Alzheimer’s disease. J Neurol Sci 110: 46–56

    Article  PubMed  CAS  Google Scholar 

  • Szelies B, Mielke R, Herholz K, Heiss W-D (1994) Quantitative topographical EEG compared to FDG PET for classification of vascular and degenerative dementia. Electroenceph Clin Neurophysiol 91: 131–139

    Article  PubMed  CAS  Google Scholar 

  • Szelies B, Mielke R, Grond M, Heiss W-D (1995) P300 in Alzheimer’s disease: relationships to dementia severity and glucose metabolism. J Neurol Sci 130: 77–81

    Article  PubMed  CAS  Google Scholar 

  • Tanna NK, Kohn MI, Horwich DN, Jolies PR, Zimmerman RA, Alves WM, Alavi A (1991) Analysis of brain cerebrospinal fluid volumes with MR imaging — impact on PET data correction for atrophy. 2. Aging and Alzheimer dementia . Radiology 178:123–130

    PubMed  CAS  Google Scholar 

  • Wisniewski KE, Wisniewski HM, Wen GY (1985) Occurrence of neuropathological changes and dementia of Alzheimer’s disease in Down’s syndrome. Ann Neurol 17: 278–282

    Article  PubMed  CAS  Google Scholar 

  • Yesavage JA, Westphal J, Rush L (1981) Senile dementia: Combined pharmacologic and psychologic treatment. J Am Geriatr Soc 29:164–171

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. W.-D. Heiss
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Szelies
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Neurologie und Psychiatrie — Psychiatrie und Psychotherapie —, Universität zu Köln, Joseph-Stelzmann-Straße 9, 50924, Köln, Germany

    J. Klosterkötter

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Heiss, WD., Szelies, B. (1998). Positronen-Emissions-Tomographie bei Demenz vom Alzheimer-Typ. In: Klosterkötter, J. (eds) Frühdiagnostik und Frühbehandlung psychischer Störungen. Bayer-ZNS-Symposium, vol 13. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72204-2_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-72204-2_21

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-64440-8

  • Online ISBN: 978-3-642-72204-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation